Table of Contents

company-logo

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Co-Diagnostics Dividend Announcement

• Co-Diagnostics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Co-Diagnostics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Co-Diagnostics Dividend History

Co-Diagnostics Dividend Yield

Co-Diagnostics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Co-Diagnostics stock? Use our calculator to estimate your expected dividend yield:

Co-Diagnostics Financial Ratios

P/E ratio-0.87
PEG ratio0.01
P/B ratio0.56
ROE-54.95%
Payout ratio0.00%
Current ratio6.92
Quick ratio6.70
Cash Ratio1.86

Co-Diagnostics Dividend FAQ

Does Co-Diagnostics stock pay dividends?
Co-Diagnostics does not currently pay dividends to its shareholders.
Has Co-Diagnostics ever paid a dividend?
No, Co-Diagnostics has no a history of paying dividends to its shareholders. Co-Diagnostics is not known for its dividend payments.
Why doesn't Co-Diagnostics pay dividends?
There are several potential reasons why Co-Diagnostics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Co-Diagnostics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Co-Diagnostics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Co-Diagnostics a dividend aristocrat?
Co-Diagnostics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Co-Diagnostics a dividend king?
Co-Diagnostics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Co-Diagnostics a dividend stock?
No, Co-Diagnostics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Co-Diagnostics stocks?
To buy Co-Diagnostics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Co-Diagnostics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.